Work

NCCTG N057K phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: A North Central Cancer Treatment Group trial.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.2031

Authors: Daniel Ma, Evanthia Galanis, David Schiff, Wenting Wu, Patrick J. Peller, Caterina Giannini, Paul D. Brown, Joon H. Uhm, Steven McGraw, Kurt A. Jaeckle, Patrick J. Flynn, Jan C. Buckner, Jann Nagina Sarkaria

Institutions: Mayo Clinic, University of Virginia Medical Center, The University of Texas MD Anderson Cancer Center, Mayo Clinic in Florida, Metro-Minnesota Community Oncology Research Consortium

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2242346661

Cites:

Cited by: 3

Related to: 10